J
Julie O. Culver
Researcher at University of Southern California
Publications - 47
Citations - 2670
Julie O. Culver is an academic researcher from University of Southern California. The author has contributed to research in topics: Genetic testing & Breast cancer. The author has an hindex of 21, co-authored 40 publications receiving 2222 citations. Previous affiliations of Julie O. Culver include City of Hope National Medical Center & Fred Hutchinson Cancer Research Center.
Papers
More filters
Journal ArticleDOI
Essential Elements of Genetic Cancer Risk Assessment, Counseling, and Testing: Updated Recommendations of the National Society of Genetic Counselors
Bronson D. Riley,Julie O. Culver,Cécile Skrzynia,Leigha Senter,June A. Peters,Josephine Wagner Costalas,Faith Callif-Daley,Sherry C. Grumet,Katherine S. Hunt,Rebecca Nagy,Wendy McKinnon,Nancie Petrucelli,Robin L. Bennett,Angela Trepanier +13 more
TL;DR: These cancer genetic counseling recommendations describe the medical, psychosocial, and ethical ramifications of counseling at-risk individuals through genetic cancer risk assessment with or without genetic testing.
Journal ArticleDOI
Genetic Cancer Risk Assessment and Counseling: Recommendations of the National Society of Genetic Counselors
Angela Trepanier,Mary Ahrens,Wendy McKinnon,June A. Peters,Jill Stopfer,Sherry C. Grumet,Susan Manley,Julie O. Culver,Ronald T. Acton,Joy Larsen-Haidle,Lori Ann Correia,Robin L. Bennett,Barbara Pettersen,Terri Diamond Ferlita,Josephine Wagner Costalas,Katherine Hunt,Susan Donlon,Cécile Skrzynia,Carolyn Farrell,Faith Callif-Daley,Catherine Walsh Vockley +20 more
TL;DR: These cancer genetic counseling recommendations describe the medical, psychosocial, and ethical ramifications of identifying at-risk individuals through cancer risk assessment with or without genetic testing.
Journal ArticleDOI
Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study
Marlies Kempers,Roland P. Kuiper,Charlotte W. Ockeloen,Pierre O. Chappuis,Pierre Hutter,Nils Rahner,Hans K. Schackert,Verena Steinke,Elke Holinski-Feder,Monika Morak,Matthias Kloor,Reinhard Büttner,Eugène T P Verwiel,J. Han van Krieken,Iris D. Nagtegaal,Monique Goossens,Rachel S. van der Post,Renee C. Niessen,Rolf H. Sijmons,Irma Kluijt,Frans B. L. Hogervorst,Edward M Leter,Johan J.P. Gille,Cora M. Aalfs,Egbert J.W. Redeker,Frederik J. Hes,Carli M. J. Tops,Bernadette P M van Nesselrooij,Marielle E. van Gijn,Encarna B. Gomez Garcia,Diana Eccles,David J. Bunyan,Sapna Syngal,Elena M. Stoffel,Julie O. Culver,Melanie R. Palomares,Tracy Graham,Lea Velsher,János Papp,Edith Olah,Tsun Leung Chan,Suet Yi Leung,Ad Geurts van Kessel,Lambertus A. Kiemeney,Nicoline Hoogerbrugge,Marjolijn J L Ligtenberg +45 more
TL;DR: The results underscore the effect of mosaic MSH2 deficiency, leading to variable cancer risks, and could form the basis of an optimised protocol for the recognition and targeted prevention of cancer in EPCAM deletion carriers.
Journal ArticleDOI
Genetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized Medicine.
TL;DR: Given the experiences and lessons learned in the genetics era, the multidisciplinary model of genetic cancer risk assessment and management will serve as a solid foundation to support the integration of personalized genomic information into the practice of cancer medicine.
Journal ArticleDOI
Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families
Xin Yang,Goska Leslie,Alicja Doroszuk,Sandra Schneider,Jamie Allen,Brennan Decker,Brennan Decker,Brennan Decker,Alison M. Dunning,James E. Redman,James Scarth,Inga Plaskocinska,Craig Luccarini,Mitul Shah,Karen A. Pooley,Leila Dorling,Andy C. H. Lee,Muriel A. Adank,Julian Adlard,Kristiina Aittomäki,Irene L. Andrulis,Peter Ang,Julian Barwell,Jonine L. Bernstein,Kristie Bobolis,Åke Borg,Carl Blomqvist,Kathleen Claes,Patrick Concannon,Adeline Cuggia,Adeline Cuggia,Julie O. Culver,Francesca Damiola,Antoine De Pauw,Orland Diez,Jill S. Dolinsky,Susan M. Domchek,Christoph Engel,D. Gareth Evans,Florentia Fostira,Judy Garber,Lisa Golmard,Ellen L. Goode,Stephen B. Gruber,Eric Hahnen,Christopher R. Hake,Tuomas Heikkinen,Judith Hurley,Ramunas Janavicius,Zdenek Kleibl,Petra Kleiblova,Irene Konstantopoulou,Anders Kvist,Holly LaDuca,Ann S.G. Lee,Ann S.G. Lee,Fabienne Lesueur,Eamonn R. Maher,Arto Mannermaa,Siranoush Manoukian,Rachel McFarland,Wendy McKinnon,Alfons Meindl,Kelly A. Metcalfe,Nur Aishah Taib,Jukka S. Moilanen,Katherine L. Nathanson,Susan L. Neuhausen,Pei Sze Ng,Tu Nguyen-Dumont,Tu Nguyen-Dumont,Sarah M. Nielsen,Florian Obermair,Kenneth Offit,Olufunmilayo I. Olopade,Laura Ottini,Judith Penkert,Katri Pylkäs,Paolo Radice,Susan J. Ramus,Susan J. Ramus,Vilius Rudaitis,Lucy Side,Rachel Silva-Smith,Valentina Silvestri,Anne-Bine Skytte,Thomas P. Slavin,Jana Soukupova,Carlo Tondini,Alison H. Trainer,Alison H. Trainer,Gary Unzeitig,Lydia Usha,Thomas van Overeem Hansen,James A. G. Whitworth,Marie E. Wood,Cheng Har Yip,Sook-Yee Yoon,Amal Yussuf,George Zogopoulos,George Zogopoulos,David E. Goldgar,John L. Hopper,Georgia Chenevix-Trench,Paul D.P. Pharoah,Sophia George,Judith Balmaña,Claude Houdayer,Claude Houdayer,Paul A. James,Paul A. James,Zaki El-Haffaf,Hans Ehrencrona,Marketa Janatova,Paolo Peterlongo,Heli Nevanlinna,Rita K. Schmutzler,Soo Hwang Teo,Mark E. Robson,Tuya Pal,Fergus J. Couch,Jeffrey N. Weitzel,Aaron Elliott,Melissa C. Southey,Melissa C. Southey,Robert Winqvist,Douglas F. Easton,William D. Foulkes,William D. Foulkes,Antonis C. Antoniou,Marc Tischkowitz +130 more
TL;DR: PALB2 is confirmed as a major breast cancer susceptibility gene and substantial associations between germline PALB2 PVs and ovarian, pancreatic, and male breast cancers are established.